These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

623 related articles for article (PubMed ID: 34676866)

  • 21. [Recommendations of the European Society of Cardiology and the European Atherosclerosis Society on Cardiovascular Disease Prevention and Management of Dyslipidemias. for the Diagnosis of Atherosclerosis and Dyslipidemia Treatment (2016): Basic S.G.].
    Bubnova MG; Kukharchuk VV
    Kardiologiia; 2017 Mar; 57(3):85-89. PubMed ID: 28762942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update on screening, etiology, and treatment of dyslipidemia in children.
    Bamba V
    J Clin Endocrinol Metab; 2014 Sep; 99(9):3093-102. PubMed ID: 24848708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
    Nesto RW
    Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: a clinical update.
    Reiner Z
    Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):799-807. PubMed ID: 23932901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of evolocumab in individuals with type 2 diabetes with and without atherogenic dyslipidemia: An analysis from BANTING and BERSON.
    Lorenzatti AJ; Monsalvo ML; López JAG; Wang H; Rosenson RS
    Cardiovasc Diabetol; 2021 Apr; 20(1):94. PubMed ID: 33941192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polygenic scores for dyslipidemia: the emerging genomic model of plasma lipoprotein trait inheritance.
    Trinder M; Brunham LR
    Curr Opin Lipidol; 2021 Apr; 32(2):103-111. PubMed ID: 33395106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apolipoprotein B and non-high-density lipoprotein cholesterol reveal a high atherogenicity in individuals with type 2 diabetes and controlled low-density lipoprotein-cholesterol.
    Fonseca L; Paredes S; Ramos H; Oliveira JC; Palma I
    Lipids Health Dis; 2020 Jun; 19(1):127. PubMed ID: 32505210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperlipidemia in coronary heart disease. 3. Evaluation of lipoprotein phenotypes of 156 genetically defined survivors of myocardial infarction.
    Hazzard WR; Goldstein JL; Schrott MG; Motulsky AG; Bierman EL
    J Clin Invest; 1973 Jul; 52(7):1569-77. PubMed ID: 4352458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-Sensitivity C-Reactive Protein Discordance With Atherogenic Lipid Measures and Incidence of Atherosclerotic Cardiovascular Disease in Primary Prevention: The ARIC Study.
    Quispe R; Michos ED; Martin SS; Puri R; Toth PP; Al Suwaidi J; Banach M; Virani SS; Blumenthal RS; Jones SR; Elshazly MB
    J Am Heart Assoc; 2020 Feb; 9(3):e013600. PubMed ID: 32013698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The treatment of dyslipidemia--what's left in the pipeline?
    Rau O; Zettl H; Popescu L; Steinhilber D; Schubert-Zsilavecz M
    ChemMedChem; 2008 Feb; 3(2):206-21. PubMed ID: 17963209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of combinations of lipid parameters with carotid intima-media thickness and coronary artery calcium in the MESA (Multi-Ethnic Study of Atherosclerosis).
    Paramsothy P; Knopp RH; Bertoni AG; Blumenthal RS; Wasserman BA; Tsai MY; Rue T; Wong ND; Heckbert SR
    J Am Coll Cardiol; 2010 Sep; 56(13):1034-41. PubMed ID: 20846602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of effects of simvastatin alone versus fenofibrate alone versus simvastatin plus fenofibrate on lipoprotein subparticle profiles in diabetic patients with mixed dyslipidemia (from the Diabetes and Combined Lipid Therapy Regimen study).
    May HT; Anderson JL; Pearson RR; Jensen JR; Horne BD; Lavasani F; Yannicelli HD; Muhlestein JB
    Am J Cardiol; 2008 Feb; 101(4):486-9. PubMed ID: 18312763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of the non-fasting lipid profile for lipid-lowering therapy in clinical practice - point of view.
    de Vries M; Klop B; Castro Cabezas M
    Atherosclerosis; 2014 Jun; 234(2):473-5. PubMed ID: 24814412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A practical approach to the laboratory diagnosis of dyslipidemia.
    Jialal I
    Am J Clin Pathol; 1996 Jul; 106(1):128-38. PubMed ID: 8701923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated triglycerides and low high-density lipoprotein cholesterol level as marker of very high risk in type 2 diabetes.
    Hermans MP; Valensi P
    Curr Opin Endocrinol Diabetes Obes; 2018 Apr; 25(2):118-129. PubMed ID: 29493554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. "If it ain't broke, don't fix it": a commentary on the positive-negative results of the ACCORD Lipid study.
    Tenenbaum A; Fisman EZ
    Cardiovasc Diabetol; 2010 Jun; 9():24. PubMed ID: 20550659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC
    Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The advantages and pitfalls of genetic analysis in the diagnosis and management of lipid disorders.
    Berberich AJ; Hegele RA
    Best Pract Res Clin Endocrinol Metab; 2023 May; 37(3):101719. PubMed ID: 36641373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Menopause symptom management in women with dyslipidemias: An EMAS clinical guide.
    Anagnostis P; Bitzer J; Cano A; Ceausu I; Chedraui P; Durmusoglu F; Erkkola R; Goulis DG; Hirschberg AL; Kiesel L; Lopes P; Pines A; van Trotsenburg M; Lambrinoudaki I; Rees M
    Maturitas; 2020 May; 135():82-88. PubMed ID: 32209279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.